EN  |  
About Us

Pharmsyn is a national Hi-Tech Enterprise which engages in the R&D/production/business development & sales on intermediates, cosmetic materials, pharmaceutical excipients and APIs, empowering development with green chemical technology and intelligent & flexible manufacturing.

While developing special technologies, Pharmsyn provides compliant, efficient and competitive pharmaceutical product solutions for global partners, with CXO (CDO, CDMO, CMO) /multi-customer products, energizing along with CMC (Chemical manufacturing control), cGMP QMS and sustainable EHS system.

Based on 20+ years accumulation of intellectual capital: innovation markets in Europe/North America/Japan, GMP CDMO business development, Pharmsyn has established a mature TQEHS management system & modern enterprise management system, with an experienced core team. Adhering to international business rules, following the spirit of IP protection and CDA, we have worked closely with domestic and worldwide pharmaceutical companies to make progress in harmony.

Pharmsyn is located in Suzhou Industrial Park and has established an international R&D team equipped with advanced experimental instruments, analytical instruments and control systems, and is committed to the process R&D, analytical development, verification, validation, and scale-up, compliance with regularlations, production transfer and commercial production on pharmaceutical small molecule compounds.

Pharmsyn has professional quality management team, based on ICH/APIC etc. regulations/guidelines, established cGMP QMS, experienced FDA/PMDA/CFDA audits for many occasions. While the project developed in R&D , Pharmsyn is trying to file more and more projects' DMF to FDA, CFDA, etc.

20+
Years Experience Accumulation
100+
Partner Pharmaceutical Companies
40+
Patents
40+
Chemical Reactions
300+
Projects
Company Vision
Vision

Become a leading pharma company featuring Green Chemical Technology and Intelligent Flexible Manufacturing, adhering to innovative R&D, regulation compliance, on pharmaceutical chemicals.

Mission

Provide Cost-efficient, and competitive pharma products for global partners;
High standard bio & pharma research;
Compliant and efficient production of intermediates, cosmetic materials, drug delivery vehicles, and APIs.

Advantages & Positioning

With CMC as the core, GMP as the foundation, flexible manufacturing as the characteristic, and strong QEHS as the guarantee;
Developing drug delivery vehicles, APIs, cosmetic materials, and specialty product services for global markets

Company Milestones
2021~2024~
●2021: Base on Suzhou R&D Center, recombinant Synthetics China into NSC-Pharmsyn, including BD/RD/PD/QEHS/CMC;
●2022-2023: Established the management System ;
Renewed the SOPs and QMS, EHSMS, etc;
Established CMC platform;
Set up the JV plants and production platform;
●2024~: Establish a Key-members shareholding platform;
Establish Specific cGMP facilities;
R&D Capability and capacity expansion;
Projects Site Change.
2021~2024~
2020~2021
●2020: Site II built up;
●2021: Sold site II to a well-known pharmaceutical company;Asset transaction completed.
2020~2021
2015~2018
●2015: Plan to construct site II in Taixing
Economic Development Zone;
Start design work in the same year;
●2017: Site II ground breaking;
●2018: Set up Suzhou R&D Center-Pharmsyn
Continued work on Site II.
2015~2018
2002~2012
●2002: JV by ZD Group & a Swiss company;
●2004: Production site A completed;
Start CDMO for EU&US;
●2008: Step into GMP;
●2010: 2nd GMP plant in site I putted into operation;
●2011: ZD acquired full ownership;
●2012: Started the Specific Generic APIs.
2002~2012